LU88102A1 - Complexes de l'acide polyadenylique avec l'acide polyuridylique - Google Patents

Complexes de l'acide polyadenylique avec l'acide polyuridylique Download PDF

Info

Publication number
LU88102A1
LU88102A1 LU88102A LU88102A LU88102A1 LU 88102 A1 LU88102 A1 LU 88102A1 LU 88102 A LU88102 A LU 88102A LU 88102 A LU88102 A LU 88102A LU 88102 A1 LU88102 A1 LU 88102A1
Authority
LU
Luxembourg
Prior art keywords
poly
composition
aids
complex
hiv
Prior art date
Application number
LU88102A
Other languages
English (en)
French (fr)
Inventor
Ara G Hovanessian
Evelyne Deschamps De Paillette
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of LU88102A1 publication Critical patent/LU88102A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU88102A 1991-04-16 1992-04-16 Complexes de l'acide polyadenylique avec l'acide polyuridylique LU88102A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108085A GB9108085D0 (en) 1991-04-16 1991-04-16 Complexes of polyadenylic acid with polyuridylic acid

Publications (1)

Publication Number Publication Date
LU88102A1 true LU88102A1 (fr) 1992-10-15

Family

ID=10693367

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88102A LU88102A1 (fr) 1991-04-16 1992-04-16 Complexes de l'acide polyadenylique avec l'acide polyuridylique

Country Status (19)

Country Link
US (2) US5756477A (ko)
EP (1) EP0509906A1 (ko)
JP (1) JPH05262653A (ko)
KR (1) KR100233393B1 (ko)
AU (1) AU656574B2 (ko)
BE (1) BE1004857A3 (ko)
CA (1) CA2066134C (ko)
CH (1) CH684521A5 (ko)
DK (1) DK51192A (ko)
DZ (1) DZ1570A1 (ko)
FR (1) FR2675384B1 (ko)
GB (2) GB9108085D0 (ko)
IE (1) IE921208A1 (ko)
LU (1) LU88102A1 (ko)
MY (1) MY108106A (ko)
NO (1) NO921513L (ko)
OA (1) OA09577A (ko)
SE (1) SE509801C2 (ko)
ZA (1) ZA922699B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
US7875283B2 (en) * 2000-04-13 2011-01-25 Advanced Cardiovascular Systems, Inc. Biodegradable polymers for use with implantable medical devices
US7186789B2 (en) * 2003-06-11 2007-03-06 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings
US20060135253A1 (en) * 2004-09-10 2006-06-22 Jeffrey George Gaming system and method for providing entry to a contest

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4940954B1 (ko) * 1970-02-16 1974-11-06
US3796631A (en) * 1970-11-09 1974-03-12 Choay Sa Processes for preparing polynucleotides
IL37076A (en) * 1971-06-16 1974-05-16 Littauer U A method for stepwise synthesis of oligoribonucleotides of defined sequence using 2'(3')-o-acyl-nucleoside diphosphates and polynucleotide phosphorylase
US4124702A (en) * 1971-07-06 1978-11-07 Merck & Co., Inc. Polynucleotides active as inducers of interferon production in living animal cells
JPS524633B2 (ko) * 1972-07-21 1977-02-05
GB1435571A (en) * 1973-04-02 1976-05-12 Searle & Co Polynucleotides
DE2319495C2 (de) * 1973-04-17 1985-01-10 Yeda Research And Development Co., Ltd., Rehovot Verfahren zum selektiven, reversiblen Binden von Biomolekülen an ein Adsorbens in einer chromatographischen Säule
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
FR2252350A1 (en) * 1973-11-22 1975-06-20 Choay Sa Polynucleotide phosphorylase - extraction from E coli, fixation on sepharose, and use in preparing polynucleotides
JPS50107187A (ko) * 1974-02-08 1975-08-23
US4006059A (en) * 1974-07-29 1977-02-01 Purdue Research Foundation Hydrophobic noncovalent binding of proteins to support materials
US4000098A (en) * 1974-08-16 1976-12-28 Palo Alto Medical Research Foundation Separation of proteins by hydrophobic adsorption
US4024241A (en) * 1974-09-27 1977-05-17 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
US4075195A (en) * 1976-08-31 1978-02-21 Kraft, Inc. Debittered protein product and method for manufacture
SU619508A1 (ru) * 1976-12-07 1978-08-15 Предприятие П/Я Г-4740 Способ получени полинуклеотидов, обладающих полирибонуклеотидфосфорилазной активностью
JPS5519239A (en) * 1978-07-28 1980-02-09 Green Cross Corp:The Interferon-producing attractant
JPS5618597A (en) * 1979-07-23 1981-02-21 Mitsubishi Chem Ind Ltd Production of oligonucleotide
US4379843A (en) * 1981-01-26 1983-04-12 Peter Cashion Immobilization of polynucleotides and polypeptides with tritylated polysaccharides
US4400375A (en) * 1981-11-23 1983-08-23 Eli Lilly And Company Tobramycin-double stranded RNA complex suitable for inducing interferon
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
US4945082A (en) * 1985-08-26 1990-07-31 Hem Research, Inc. Controlled dsRNA therapy for human viral infections
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4820696A (en) * 1985-08-26 1989-04-11 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAS
US5063209A (en) * 1985-08-26 1991-11-05 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAs
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
US5091374A (en) * 1987-07-17 1992-02-25 Hem Research Inc. Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
GB8725606D0 (en) * 1987-11-02 1987-12-09 Soc D Etudes Prod Chimique Preparation polynucleotides
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法

Also Published As

Publication number Publication date
US5756477A (en) 1998-05-26
DZ1570A1 (fr) 2002-02-17
OA09577A (fr) 1993-01-31
FR2675384B1 (fr) 1995-09-15
EP0509906A1 (fr) 1992-10-21
GB9207798D0 (en) 1992-05-27
SE9201207D0 (sv) 1992-04-15
AU1490992A (en) 1992-10-22
JPH05262653A (ja) 1993-10-12
KR100233393B1 (ko) 1999-12-01
ZA922699B (en) 1992-12-30
NO921513D0 (no) 1992-04-15
GB2255504A (en) 1992-11-11
AU656574B2 (en) 1995-02-09
CH684521A5 (fr) 1994-10-14
IE921208A1 (en) 1992-10-21
BE1004857A3 (fr) 1993-02-09
CA2066134C (en) 2002-11-19
KR920019363A (ko) 1992-11-19
SE509801C2 (sv) 1999-03-08
DK51192A (da) 1992-10-17
SE9201207L (sv) 1992-10-17
MY108106A (en) 1996-08-15
GB9108085D0 (en) 1991-06-05
FR2675384A1 (fr) 1992-10-23
DK51192D0 (da) 1992-04-15
NO921513L (no) 1992-10-19
US5736525A (en) 1998-04-07
CA2066134A1 (en) 1992-10-17

Similar Documents

Publication Publication Date Title
FR2615394A1 (fr) Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales
EP0951473A1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
EP0591281A1 (fr) Composes immunogenes a effet notamment anti-cytokine, procede de preparation, compositions pharmaceutiques et kits les renfermant
FR2643557A1 (fr) Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv
EP0542630A2 (fr) Utilisation de dérivés d'amphotéricine B, comme inhibiteurs de protéases
BE1004857A3 (fr) Complexes de l'acide polyadenylique avec l'acide polyuridylique.
EP0394112A2 (fr) Utilisation de dipyrido (4,3-b)(3,4-f) indoles pour la préparation de médicaments utiles pour le traitement du SIDA
EP0605700B1 (fr) Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih
EP0185584B1 (fr) Utilisation de l'hétéropolyanion (NaSb9W21086)18- pour fabriquer une composition pharmaceutique destinée à être utilisée dans le traitement du sida et des syndromes analogues
EP0427843B1 (fr) Produit inhibiteur specifique de la transcriptase inverse de retrovirus, et son application comme medicament
WO1990014086A1 (fr) Utilisation de derives de l'acridine dans le traitement d'infections retrovirales chez l'homme
EP0357495A2 (fr) Dérivés de la 3'azido-3' déoxythymidine (AZT) actifs contre le virus du sida
EP0286491A1 (fr) Dérivés d'aminoquinoléine antimalarique, procédé de préparation et composition pharmaceutique en contenant
EP0316212B1 (fr) Application de nitrophényles ou d'anticorps anti-nitrophényles à la modification de l'interaction entre des cellules sensibles d'un hôte et un agent pathogene
EP1001789B1 (fr) Produit comprenant au moins un arn double brin en association avec au moins un derive du 6-benzyluracil pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
FR2711527A1 (fr) Utilisation de l'acriflavine comme agent anti HIV.
FR2647017A1 (fr) Agent antitumoral et agent antimetastatique contenant un inhibiteur de la ribonuclease comme composant actif
FR2646353A1 (fr) Utili sation de peptides contenant de la statine pour la preparation de medicaments utiles pour le traitement des maladies virales
FR2645020A1 (fr) Medicament pour le traitement des maladies infectieuses dues aux retrovirus ainsi que pour le traitement des tumeurs
FR2646354A1 (fr) Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
FR2739560A1 (fr) Utilisation d'un polypeptide ayant l'activite du cd16 humain soluble dans le traitement de l'infection par le virus vih
JPH0586927B2 (ko)
JPH02504283A (ja) 芳香族多環式ジオン化合物とヌクレオシド類似化合物とを含む抗ウイルス性組成物及びレトロウイルス感染を治療するための方法
CA2373991A1 (fr) Utilisation d'anticorps reconnaissant le recepteur de l'interleukine-2 dans la prevention et/ou le traitement des infections par les virus du sida
FR2686884A1 (fr) Fragments de la jacaline et leur utilisation comme medicament, notamment dans le traitement des maladies liees aux virus hiv.